[Artery denuded model and effects of three kinds of antisense c-myc RNA]

Zhonghua Yi Xue Za Zhi
|January 19, 2002
PubMed
Abstract

Insights

Antisense c-myc therapy effectively reduces neointimal hyperplasia in injured rabbit arteries. The c-myc exon 2 antisense RNA vector (aM2) demonstrated the most significant reduction in neointimal hyperplasia and smooth muscle cell dedifferentiation.

Area of Science:

  • Vascular Biology
  • Molecular Medicine
  • Gene Therapy

Context:

  • Vascular injury triggers cellular proliferation, leading to neointimal hyperplasia.
  • The c-myc oncogene plays a critical role in vascular smooth muscle cell proliferation and differentiation.

Purpose:

  • To investigate the therapeutic potential of antisense c-myc in mitigating neointimal hyperplasia following vascular injury.
  • To evaluate the efficacy of different antisense c-myc exon vectors in a rabbit femoral artery denudation model.

Summary:

  • Three antisense c-myc retroviral vectors (aM1, aM2, aM3) were introduced into injured rabbit femoral arteries.
  • Antisense c-myc significantly reduced neointimal area, suppressed c-myc expression, and inhibited smooth muscle cell dedifferentiation, with aM2 showing the greatest effect.
  • PCNA and alpha-SM actin expression patterns indicated reduced proliferation and enhanced differentiation in antisense-treated groups.

Impact:

  • The rabbit femoral artery denudation model is validated as suitable for studying vascular injury responses.
  • Antisense c-myc gene therapy presents a promising strategy to prevent or treat neointimal hyperplasia and associated vascular remodeling.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...